![Wei Fu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wei Fu
Voorzitter bij
NOVABRIDGE BIOSCIENCES
Vermogen: 89 M $ op 31-05-2026
Profiel
De heer Wei Fu is Onafhankelijk Bestuurder bij I-Mab, Voorzitter bij Everest Medicines Ltd., Chief Executive Officer bij Shanghai Kangshiqiao Business Consulting Co. Ltd., een Chief Executive Officer & Managing Partner bij C-Bridge Capital Investment Management Ltd. en een Chief Executive Officer bij Cbc Group Co. Ltd. Hij zetelt in de Raad van Bestuur van I-Mab, Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., Everest Medicines (Singapore) Pte Ltd., Everest Medicines II BVI Ltd., Everest Medicines II HK Ltd., Everest Medicines II Ltd., Everonc Medicines Ltd. en Everonc Medicines, Inc. Voorheen was de heer Fu werkzaam als General Manager-Investment Department bij Far East Horizon Ltd., Head-Beijing Officer bij Themes Investment Management Ltd., Associate Director-Private Equity Department bij Standard Chartered Business Consulting Beijing Co. Ltd., en niet-uitvoerend bestuurder bij Ascletis Pharma, Inc. Hij behaalde zijn doctorale graad aan de Nanyang Technological University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 21.683.167 ( 6,13% ) | 83 M $ | 31-05-2026 | |
| 29-06-2026 | 7.129.885 ( 3,76% ) | 6 M $ | 30-06-2026 |
Laatste nieuws over Wei Fu
Actieve functies van Wei Fu
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Voorzitter | 15-07-2024 |
| EVEREST MEDICINES LIMITED | Directeur/Bestuurslid | 09-10-2025 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Algemeen Directeur | 01-01-2014 |
Everest Medicines (Singapore) Pte Ltd. | Directeur/Bestuurslid | - |
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Directeur/Bestuurslid | - |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Voorzitter | - |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Directeur/Bestuurslid | - |
Everest Medicines II BVI Ltd. | Directeur/Bestuurslid | - |
Everest Medicines II HK Ltd. | Directeur/Bestuurslid | - |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Eerdere bekende functies van Wei Fu
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Wei Fu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
85
Eerstegraads connecties
21
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 21 |
|---|---|
Nanyang Technological University
 Nanyang Technological University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management invests in companies located in China. It provides financing for buyout and special situation transactions. It also makes co-investment. | Finance |
Far East Horizon Ltd.
 Far East Horizon Ltd. Finance/Rental/LeasingFinance Provides financial and advisory & industrial operation services | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Manufactures therapeutic products | Health Technology |
Hugel, Inc.
 Hugel, Inc. BiotechnologyHealth Technology Manufactures and supplies toxin products, cosmetics, medical devices and pharmaceuticals | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Ascletis Pharma, Inc.
 Ascletis Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology firm which develops drugs for HIV, HCV and HBV diseases | Health Technology |
CBC Group Co., Ltd. | |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutics for ophthalmology patients | Health Technology |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
C-Bridge Capital Investment Management Ltd. | |
Standard Chartered Business Consulting Beijing Co. Ltd. | |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Everest Medicines II HK Ltd. | |
Everest Medicines (Singapore) Pte Ltd. | |
Everonc Medicines Ltd. | |
Everonc Medicines, Inc. | |
Everest Medicines II BVI Ltd. | |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
C-Bridge Capital GP IV Ltd.
C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
